New Key Statistics Module, Z-Score and F-Score
NAS:IOVA Key Ratios
Market Cap $ M | 2,896.27 |
Enterprise Value $ M | 2,593.66 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.26 |
Price/Sales | 1,293.79 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -1.80 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -9.90 |
5-y EBITDA Growth Rate % | -8.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.55 |
EV-to-EBITDA | -6.03 |
PEG | -- |
Shares Outstanding M | 279.83 |
Net Margin (%) | -23,615.70 |
Operating Margin % | -24,549.63 |
Pre-tax Margin (%) | -23,872.37 |
Quick Ratio | 4.42 |
Current Ratio | 4.63 |
ROA % (ttm) | -55.04 |
ROE % (ttm) | -70.61 |
ROIC % (ttm) | -107.60 |
Dividend Yield % | -- |
Altman Z-Score | 4.33 |
IOVA Number of Guru Trades
IOVA Volume of Guru Trades
Gurus Latest Trades with NAS:IOVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IOVA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Iovance Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:IOVA
Total 0- 1